Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media

Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media: A Randomized Controlled Trial by Time-Lapse System- Single Step vs Sequential Media

This is a randomized, controlled, single-center study in otherwise healthy infertile female subjects undergoing in vitro fertilization (IVF). The subjects recruited for this study will be among those patients who have been diagnosed with infertility and are planning to undergo IVF at the centers where this study is being performed. The patients will have undergone the usual informed consent procedure at the center.

Study Overview

• Status: Terminated
• Conditions: Infertility
• Intervention / Treatment: Other: embryo culture in buffered media

Detailed Description

Subjects will undergo ovarian stimulation, oocyte retrieval, IVF, and Intra Cytoplasmic Sperm Injection (ICSI) procedure following the center's usual procedures. The cohort of injected oocytes from each patient will be randomly divided between the one step and sequential medias: CRM (Cornell- Center for Reproductive Medicine) media (C1/C2 or C3) vs G-TL Time Lapse media or G-1/G-2 media. Single step or sequential media are both buffered mediums for culture from oocyte fertilization to blastocyst stage. Sequential media is formulated according to the stages of embryo development and embryos are re-cultured in medias according to their stage of development. Single step (time lapse) media is formulated for continuous culture from D0 to Day 5/6.

Mature oocytes will be randomized via a non-bias computer program into two to four of the study groups: G-TL commercial single step (Vitrolife), Vitrolife's sequential media, Cornell's single step , and Cornell's sequential media. Oocytes will be divided randomly among the various media dependent upon the number of mature oocytes. I.e.: 10 oocytes injected = 2 media groups; 15 oocytes injected = up to 3 media groups; 20 oocytes injected = up to 4 media groups.

"Best grade" embryos will be transferred regardless of media source. If embryos are transferred from multi-source media and if researchers are unable to determine the media source after transfer, the subject will not be included in the outcome data portion of the study- e.g pregnancy outcome.

The Time-Lapse monitoring system will be used as standard clinical practice to observe development and document timing of embryo cleavages and morphology dynamics.

Endpoints will be Day 3 and Day 5/6 embryo development, implantation and pregnancy rate. The study is approximately 2 months, the estimated time it takes a physician to perform one IVF-ART IVF- Assisted Reproductive Technology) treatment cycle. If embryos are frozen, the patient may be in the study until the time they choose to thaw the embryos or up to 1 year if they become pregnant.

• Study Type: Interventional
• Enrollment (Actual): 13
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • New York
    • New York, New York, United States, 10021
      • Center fo Reproductive Medicine

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 40 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• 40 years of age or younger (maternal) 65 years of age or younger (paternal)
• Patient must have 10 or greater than 10 mature oocytes, ICSI only
• Fresh or frozen (including donor) sperm can be used. Fresh oocytes only (including donor)
• Frozen embryos from this study can be included in the outcome portion of this study.
• Single or double Blastocyst transfer only

Exclusion Criteria:

• Patients having PGS (Pre-implantation Genetic Screening)
• 3 or more previous failed cycles
• Sperm obtained by testicular biopsy
• Previous enrollment in the study
• Non blastocyst transfer
• Co-culture patients
• Outcome data portion exclusion only:

Multi-source media transfers if researchers are unable to determine the media source after transfer.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: CRM sequential media (C1/C2); CRM sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage.	Other: embryo culture in buffered media; compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.; Other Names: Embryo media- CRM media vs Vitrolife
Active Comparator: CRM single step media (C3); CRM single step media is used to culture the embryos from oocyte fertilization to blastocyst stage.	Other: embryo culture in buffered media; compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.; Other Names: Embryo media- CRM media vs Vitrolife
Experimental: Vitrolife media G1/2 Sequential; Vitrolife sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage.	Other: embryo culture in buffered media; compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.; Other Names: Embryo media- CRM media vs Vitrolife
Experimental: Vitrolife G-TL Time Lapse media Single Step; G-TL Time Lapse Single step (time lapse) media is formulated for continuous culture from oocyte fertilization to blastocyst stage.	Other: embryo culture in buffered media; compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.; Other Names: Embryo media- CRM media vs Vitrolife

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Embryo development	Comparison of embryo development using standard assessments of morphokenetics of embryo development	1 year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Embryo transfer rate	Percentage of embryo transferred in each arm.	1 year
Clinical pregnancy rates	Percentage of embryos transferred that implant into the uterus by evidence of a fetal sac by ultrasound	within 3 months of embryo transfer

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of participants pregnant after Frozen Embryo Transfer	Pregnancy rate from frozen embryo transfer in each arm.	2 years

Collaborators and Investigators

• Sponsor: Weill Medical College of Cornell University
• Collaborators: Vitrolife

Study record dates

Study Major Dates

• Study Start: July 1, 2015
• Primary Completion (Actual): October 17, 2016
• Study Completion (Actual): April 1, 2017

Study Registration Dates

• First Submitted: July 28, 2015
• First Submitted That Met QC Criteria: August 17, 2015
• First Posted (Estimate): August 19, 2015

Study Record Updates

• Last Update Posted (Actual): May 1, 2017
• Last Update Submitted That Met QC Criteria: April 27, 2017
• Last Verified: April 1, 2017

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Infertility
• Other Study ID Numbers: 1411015635

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No